FAP and neoplasm: We posited that these novel boronic acid-based tracers may exhibit a higher tumor uptake by virtue of their more potent FAP inhibition and demonstrate superior pharmacokinetics by undergoing quick clearance from all the non-target organs/tissues and serve as PET imaging agents with excellent imaging contrast.